Adiponectin, a hormone derived from adipose tissue, has emerged as a potential therapeutic target in AD due to its diverse physiological roles [12] and involvement in various neurological processes [13,14,15]. The gene discussed is ADIPOQ; the disease is Alzheimer disease.